Kancera AB (publ) KAN.ST Stock
1.67 SEK
{{ price }}
-0.238953%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
202.38M SEK
LOW - HIGH [24H]
1.67
-
1.74 SEK
VOLUME [24H]
245.23K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.7 SEK
Kancera AB (publ) Price Chart
Kancera AB (publ) KAN.ST Financial and Trading Overview
| Kancera AB (publ) stock price | 1.67 SEK |
| Previous Close | 2.82 SEK |
| Open | 2.82 SEK |
| Bid | 2.74 SEK x 0 |
| Ask | 2.75 SEK x 0 |
| Day's Range | 2.71 - 2.82 SEK |
| 52 Week Range | 1.96 - 6.47 SEK |
| Volume | 39.12K SEK |
| Avg. Volume | 89.56K SEK |
| Market Cap | 225.7M SEK |
| Beta (5Y Monthly) | 1.23908 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KAN.ST Valuation Measures
| Enterprise Value | 148.14M SEK |
| Trailing P/E | N/A |
| Forward P/E | -8.058824 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.4377224 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Kancera AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.23908 |
| 52-Week Change | -45.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.47 SEK |
| 52 Week Low | 1.96 SEK |
| 50-Day Moving Average | 3.05 SEK |
| 200-Day Moving Average | 3.23 SEK |
KAN.ST Share Statistics
| Avg. Volume (3 month) | 89.56K SEK |
| Avg. Daily Volume (10-Days) | 60.59K SEK |
| Shares Outstanding | 81.51M |
| Float | 76.43M |
| Short Ratio | N/A |
| % Held by Insiders | 20.89% |
| % Held by Institutions | 4.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.76% |
| Return on Equity (ttm) | -57.99% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.01 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -57975000 SEK |
| Diluted EPS (ttm) | -0.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.13M SEK |
| Total Cash Per Share (mrq) | 0.96 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.455 |
| Book Value Per Share (mrq) | 1.124 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -57214000 SEK |
| Levered Free Cash Flow (ttm) | -35825624 SEK |
Profile of Kancera AB (publ)
| Country | Sweden |
| State | N/A |
| City | Solna |
| Address | Karolinska Institutet Science Park |
| ZIP | 171 65 |
| Phone | 46 8 50 12 60 80 |
| Website | https://www.kancera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.
Q&A For Kancera AB (publ) Stock
What is a current KAN.ST stock price?
Kancera AB (publ) KAN.ST stock price today per share is 1.67 SEK.
How to purchase Kancera AB (publ) stock?
You can buy KAN.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kancera AB (publ)?
The stock symbol or ticker of Kancera AB (publ) is KAN.ST.
Which industry does the Kancera AB (publ) company belong to?
The Kancera AB (publ) industry is Biotechnology.
How many shares does Kancera AB (publ) have in circulation?
The max supply of Kancera AB (publ) shares is 121.19M.
What is Kancera AB (publ) Price to Earnings Ratio (PE Ratio)?
Kancera AB (publ) PE Ratio is now.
What was Kancera AB (publ) earnings per share over the trailing 12 months (TTM)?
Kancera AB (publ) EPS is -0.7 SEK over the trailing 12 months.
Which sector does the Kancera AB (publ) company belong to?
The Kancera AB (publ) sector is Healthcare.
Kancera AB (publ) KAN.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North All-Share SEK FIRSTNORTHSEK | 126.34 SEK 12.33 USD |
-0.9
|
— — | 126.23 SEK 12.32 USD | 127.53 SEK 12.45 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.04 DKK 14.82 USD |
-1.33
|
— — | 100.96 DKK 14.8 USD | 102.42 DKK 15.02 USD | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 2001.34 SEK 195.36 USD |
-1.07
|
— — | 1999.37 SEK 195.16 USD | 2020.41 SEK 197.22 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1616.97 EUR 1767.57 USD |
-1.5
|
— — | 1615.38 EUR 1765.82 USD | 1639.39 EUR 1792.08 USD | — - | — — |
| First North Health Care GI FN20GI | 939.04 EUR 1026.5 USD |
-1.95
|
— — | 937.79 EUR 1025.13 USD | 957.74 EUR 1046.94 USD | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 100.98 EUR 110.38 USD |
-1.33
|
— — | 100.89 EUR 110.29 USD | 102.35 EUR 111.88 USD | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1878.6 SEK 183.37 USD |
+0.16
|
— — | 1870.08 SEK 182.54 USD | 1889.76 SEK 184.46 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1513.01 EUR 1653.92 USD |
+0.67
|
— — | 1510.95 EUR 1651.67 USD | 1533.41 EUR 1676.23 USD | — - | — — |
| First North Health Care PI FN20PI | 934.74 EUR 1021.8 USD |
-1.95
|
— — | 933.5 EUR 1020.44 USD | 953.35 EUR 1042.15 USD | — - | — — |
- {{ link.label }} {{link}}